Clinical Trial Update: A Study of AL2846 Versus Zoledronic Acid in Subjects With Advanced Non-Small Cell Lung Cancer With Bone Metastasis [Phase 2]

View source ↗

Summary

Phase 2 study comparing AL2846 to zoledronic acid in subjects with bone-metastatic non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer with Bone Metastasis

Drugs mentioned

• AL2846
• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Bone Metastatic Non-small Cell Lung Cancer | Phase 2 | Status: UNKNOWN